NDC 15054-0500-1 Dysport
Botulinum Toxin Type A Injection, Powder, Lyophilized, For Solution Intramuscular
NDC Package Code 15054-0500-1
The NDC Code 15054-0500-1 is assigned to a package of 1 vial in 1 carton > 1 injection, powder, lyophilized, for solution in 1 vial of Dysport, a human prescription drug labeled by Ipsen Biopharmaceuticals, Inc.. The product's dosage form is injection, powder, lyophilized, for solution and is administered via intramuscular form.This product is billed for "EA" each discreet unit and contains an estimated amount of 1 billable units per package.
NDC Code Structure
- 15054 - Ipsen Biopharmaceuticals, Inc.
- 15054-0500 - Dysport
- 15054-0500-1 - 1 VIAL in 1 CARTON
- 15054-0500 - Dysport
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the disclaimer below.
NDC HCPCS Crosswalk
This crosswalk is intended to help the public understand which drug products (identified by NDCs) are assigned to which HCPCS billing codes.
NDC 15054-0500-1 HCPCS crosswalk information with package details and bill units information.
NDC Billing Code | HCPCS Code | HCPCS Code Desc. | Dosage | Package Size | Package Quantity | Billable Units | Billable Units / Pkg |
---|---|---|---|---|---|---|---|
15054050001 | J0586 | Abobotulinumtoxina | 5 Unit | 1 | 1 | 100 | 100 |
* Please review the disclaimer below.
Other Product Packages
The following packages are also available for Dysport with product NDC 15054-0500.
NDC Package Code | Package Description |
---|---|
15054-0500-2 | 2 VIAL in 1 CARTON > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL |
15054-0500-9 | 1 VIAL in 1 CARTON > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL |
* Please review the disclaimer below.